Long-term outcomes of ALK inhibitors in metastatic ALK-positive non-small cell lung cancer: an updated indirect comparison using reconstructed patient-level data

Andrea Ossato, Vera Damuzzo, Luna Del Bono, Lorenzo Gasperoni, Tiziano Lupi, Arianna Colicchio, Stefania Gori, Alessandro Inno